Roche's six-hour sepsis test:
This article was originally published in Clinica
Executive Summary
Roche has CE-marked for sale in Europe a PCR-based test for sepsis that can identify the infection in less than six hours. The LightCycler SeptiFast test can detect several sepsis-causing pathogens simultaneously from just a three-millilitre sample of blood. It can detect and identify 25 different pathogens - including bacteria and fungi - which cause around 90% of all sepsis cases, said the Basel, Switzerland-based firm. Traditional tests for sepsis pathogens generally take from two to five days to complete, and up to eight days for the diagnosis of fungal infections, said the company. Roche noted that severe sepsis accounts for up to 135,000 European and 215,000 American deaths each year.
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.